test CALIFORNIA NANOTECHNOLOGIES ISSUES STOCK OPTIONS Management Discussion & Analysis For the fiscal nine months ended November 30, 2022 Condensed Consolidated Interim Financial Statements For the nine months ended November 30, 2022 CALIFORNIA NANOTECHNOLOGIES ANNOUNCES Q3/FY2023 RESULTS AND DEBT REPAYMENT

Nov-2021 Oct-2021 Jul-2021 Jun-2021 Feb-2021 Jan-2020 Dec-2020 Oct-2020 Aug-2020 Jul-2020 Jun-2020 Feb-2020 Dec-2019 Oct-2019 Aug-2019 Jul-2019 Apr-2019 Jan-2019 Dec-2018 Oct-2018 Aug-2018 Jul-2018 Jun-2018 Mar-2018 Nov-2017 Oct-2017 Aug-2017 Jul-2017 Jun-2017 Mar-2017 Jan-2017 Dec-2016 Nov-2016 Sep-2016 Aug-2016 Jun-2016 May-2016 Apr-2016 Feb-2016 Oct-2015 Sep-2015 Aug-2015 Jul-2015 Jun-2015 May-2015 Mar-2015 Feb-2015 Oct-2014 Aug-2014 Jul-2014 Jun-2014 May-2014 Apr-2014 Mar-2014 Jan-2014 Dec-2013 Jul-2013 Nov-2013 Oct-2013 Aug-2013 Aug-2021 May-2021 Nov-2020 May-2020 Nov-2019 May-2019 Feb-2019 Nov-2018 May-2018 Feb-2018 May-2017 Feb-2017 Nov-2015 Nov-2014 Feb-2014 May-2013 Feb-2012 Nov-2012 Aug-2012 May-2012 Jan-2022 Feb-2022 May-2022 Jun-2022 Nov-2022 Dec-2022 Aug-2022 Jan-2023 Feb-2023 Mar-2023 Mar-2022